Mannkind (MNKD) EBITDA (2010 - 2026)
Mannkind (MNKD) posted EBITDA of $6.05 million for Q2 2026, down 18.1% from $7.39 million a year earlier but up 28.3% from the prior quarter.
Powered by 
Analysis
Mannkind (MNKD) EBITDA (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA at Mannkind was $30.06 million, down 60.1% year-over-year; for FY2025, it came in at $51.09 million, down 36.1% from FY2024.
- In prior years, Mannkind's EBITDA was $79.96 million in FY2024 (+505.1%), $13.21 million in FY2023, -$60.79 million in FY2022 and -$45.04 million in FY2021.
- Quarterly EBITDA has run from a low of -$24.98 million in Q4 2021 to a high of $28.66 million in Q4 2024 over five years.
- On a year-over-year basis, EBITDA increased in four of the last seven quarters, with growth averaging 39.3%.
- The strongest year-over-year quarter for EBITDA in the past five years was Q2 2024, with growth of 524.1%; the weakest was Q1 2026, with a decline of 80.7%.
- According to Business Quant data, EBITDA for the three prior quarters was $4.72 million (Q1 2026), -$1.66 million (Q4 2025) and $20.96 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.61 Bn | 1,103.20 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 616.25 Bn | 534.77 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 501.45 Bn | 474.56 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 297.99 Bn | 261.98 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.44 Bn | 235.12 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 235.87 Bn | 191.27 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 169.40 Bn | 116.05 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Mannkind | 955.40 Mn | 276.04 Mn | 94.97 Mn | 6.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.46 Mn |
| Mar 31, 2026 | 5.17 Mn |
| Dec 31, 2025 | -1.18 Mn |
| Sep 30, 2025 | 21.06 Mn |
| Jun 30, 2025 | 7.44 Mn |
| Mar 31, 2025 | 24.51 Mn |
| Dec 31, 2024 | 28.97 Mn |
| Sep 30, 2024 | 15.24 Mn |
| Jun 30, 2024 | 18.70 Mn |
| Mar 31, 2024 | 18.58 Mn |
| Dec 31, 2023 | 9.60 Mn |
| Sep 30, 2023 | 6.49 Mn |
| Jun 30, 2023 | 3.30 Mn |
| Mar 31, 2023 | -4.47 Mn |
| Dec 31, 2022 | -11.25 Mn |
| Sep 30, 2022 | -8.27 Mn |
| Jun 30, 2022 | -19.36 Mn |
| Mar 31, 2022 | -20.19 Mn |
| Dec 31, 2021 | -24.98 Mn |
| Sep 30, 2021 | -5.27 Mn |
API Access
Mannkind EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=MNKD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "MNKD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=MNKD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();